Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same

Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same

US Patent 11021469 · Granted Jun 1, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Carborane hydroxamic acid matrix metalloproteinase inhibitors and agents for bor2024
Carborane hydroxamic acid matrix metalloproteinase inhibitors and agents for bor2023
Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use2020
Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use2020
Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use2020
Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use2020
Inhalation device and method2019
Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same2019
Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same2019
Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same2019
Inhaler and methods of use thereof2019
Inhalation device and method2018